These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 2405804

  • 1. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR.
    Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
    [Abstract] [Full Text] [Related]

  • 2. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Feb; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 3. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
    O'Brien RC, Simons LA, Clifton P, Cooper ME, Jennings GL, Jerums G, Nestel PJ, Sullivan D.
    Med J Aust; 1990 May 07; 152(9):480-3. PubMed ID: 2199801
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun 14; 153(11):1321-9. PubMed ID: 8507122
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M, Bonnefous F, Debbas N, Irvine A.
    Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177
    [Abstract] [Full Text] [Related]

  • 6. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J, Oette K, Burrichter H.
    Fortschr Med; 1990 Feb 10; 108(4):71-2, 75-6. PubMed ID: 2312032
    [Abstract] [Full Text] [Related]

  • 7. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
    Leclercq V, Harvengt C.
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb 10; 27(2):76-81. PubMed ID: 2921098
    [Abstract] [Full Text] [Related]

  • 8. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
    Mabuchi H, Sakai T, Sakai Y, Yoshimura A, Watanabe A, Wakasugi T, Koizumi J, Takeda R.
    N Engl J Med; 1983 Mar 17; 308(11):609-13. PubMed ID: 6828091
    [Abstract] [Full Text] [Related]

  • 9. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
    Mol MJ, Stuyt PM, Demacker PN, Stalenhoef AF.
    Neth J Med; 1990 Apr 17; 36(3-4):182-90. PubMed ID: 2355995
    [Abstract] [Full Text] [Related]

  • 10. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O, Pancallo MT, Della Valle M, Marasco A, Malarbi AL.
    Clin Ter; 1991 Jun 15; 137(5):333-7. PubMed ID: 1832606
    [Abstract] [Full Text] [Related]

  • 11. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
    JAMA; 1988 Jul 15; 260(3):359-66. PubMed ID: 2898027
    [Abstract] [Full Text] [Related]

  • 12. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1996 Jan 15; 77A():28-32. PubMed ID: 8729588
    [Abstract] [Full Text] [Related]

  • 13. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec 15; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
    Mol MJ, Stuyt PM, Stalenhoef AF.
    Ned Tijdschr Geneeskd; 1989 Feb 18; 133(7):362-6. PubMed ID: 2927555
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
    Marnini P, Colombo F, Cattaneo R, Geroli L, Venco A.
    Int J Clin Pharmacol Res; 1992 Feb 18; 12(2):65-70. PubMed ID: 1428300
    [Abstract] [Full Text] [Related]

  • 16. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M, Lupien PJ, Gagné C, Lévy E, Blaichman S, Langlois S, Hayden M, Rose V, Clarke JT, Wolfe BM, Clarson C, Parsons H, Stephure DK, Potvin D, Lambert J.
    Pediatrics; 1996 May 18; 97(5):619-28. PubMed ID: 8628597
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun 18; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 18. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
    Brocard JJ, Keller U, Oberhänsli A, Riesen WF.
    Schweiz Med Wochenschr; 1991 Jun 29; 121(26):977-83. PubMed ID: 1862314
    [Abstract] [Full Text] [Related]

  • 19. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec 29; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of simvastatin and cholestyramine on plasma lipoproteins and CETP in humans.
    McPherson R.
    Can J Clin Pharmacol; 1999 Dec 29; 6(2):85-90. PubMed ID: 10519734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.